In Vivo Activation of Naive CD4+ T Cells in Nasal Mucosa-Associated Lymphoid Tissue following Intranasal Immunization with Recombinant Streptococcus gordonii

D Medaglini, A Ciabattini, AM Cuppone… - Infection and …, 2006 - Am Soc Microbiol
The antigen-specific primary activation of CD4+ T cells was studied in vivo by adoptive
transfer of ovalbumin-specific transgenic T cells (KJ1-26+ CD4+) following intranasal …

Evaluation of the effect of MPL and delivery route on immunogenicity and protectivity of different formulations of FimH and MrpH from uropathogenic Escherichia coli …

M Habibi, MRA Karam, S Bouzari - International Immunopharmacology, 2015 - Elsevier
Urinary tract infections (UTIs) caused by Escherichia coli and Proteus mirabilis are an
important cause of morbidity and with the high rate of relapse and spread of multi-drug …

Stimulation of Human Monocytes with the Gram-Positive Vaccine Vector Streptococcus gordonii

A Ciabattini, AM Cuppone, R Pulimeno… - Clinical and vaccine …, 2006 - Am Soc Microbiol
Streptococcus gordonii is a bacterial vaccine vector which has previously been shown to
activate dendritic cells in vitro and to induce local and systemic immune responses in vivo. In …

Identification of the chain-dispersing peptidoglycan hydrolase LytB of Streptococcus gordonii

R Arrigucci, G Pozzi - PLoS One, 2017 - journals.plos.org
Bacterial cell division ends with the separation of the daughter cells, a process that requires
peptidoglycan hydrolases (PGHs). Bacteria lacking cell separating PGHs are impaired in …

Rapid induction of autoantibodies against Nogo‐A and MOG in the absence of an encephalitogenic T cell response: implication for immunotherapeutic approaches in …

D Merkler, T Oertle, A Buss, DD Pinschewer… - The FASEB …, 2003 - Wiley Online Library
Vaccinations against various antigens of the central nervous system (CNS) are gaining
increasing interest as a therapeutic approach in a variety of neurological diseases such as …

Engineering of staphylococcal surfaces for biotechnological applications

H Wernérus, J Lehtiö, P Samuelson, S Ståhl - Journal of biotechnology, 2002 - Elsevier
Novel surface proteins can be introduced onto bacterial cell surfaces by recombinant
means. Here, we describe various applications of two such display systems for the food …

Discovery and engineering of the antibody response against a prominent skin commensal

DA Bousbaine, K Bauman, YE Chen, V Yu, P Lalgudi… - bioRxiv, 2024 - biorxiv.org
The ubiquitous skin colonist Staphylococcus epidermidis elicits a CD8+ T cell response pre-
emptively, in the absence of an infection1. However, the scope and purpose of this anti …

Expression and Immunogenicity of a Recombinant Diphtheria Toxin Fragment A in Streptococcus gordonii

CW Lee, SF Lee, SA Halperin - Applied and environmental …, 2004 - Am Soc Microbiol
ABSTRACT A nontoxic mutant diphtheria toxin fragment A (DTA) was genetically fused in
single, double, or triple copy to the major surface protein antigen P1 (SpaP) and surface …

[PDF][PDF] Microbial cell surface display; its medical and environmental applications

V Tafakori, I Torktaz, M Doostmohammadi… - Iranian Journal of …, 2012 - ijbiotech.com
Cell-surface display is the expression of peptides and proteins on the surface of living cells
by fusing them tofunctional components of cells which are exposed to the environment of …

Immunotherapy for ovarian cancer is improved by tumor targeted delivery of a neoantigen surrogate

LR Scanlon, L Gabor, O Khouri, S Ahmad, E Levy… - bioRxiv, 2023 - biorxiv.org
Ovarian cancer is known for its poor neoantigen expression and strong immunosuppression.
Here, we utilized an attenuated non-pathogenic bacterium Listeria monocytogenes …